Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Mackness

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Journal of Hepatology|March 3, 2006
Paraoxonase-1 is associated with oxidative stress, fibrosis and FAS expression in chronic liver diseasesNatàlia Ferré, Judit Marsillach, Jordi Camps, et al.
Journal of Molecular Histology|October 9, 2010
Tissue distribution and expression of paraoxonases and chemokines in mouse: the ubiquitous and joint localisation suggest a systemic and coordinated roleFernando Rodríguez-Sanabria, Anna Rull, Raúl Beltrán-Debón, et al.
Circulation|July 21, 2004
Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in womenMasoud El-Magadmi, Helena Bodill, Yasmeen Ahmad, et al.
Mediators of Inflammation|June 15, 2013
Paraoxonase-1 inhibits oxidized low-density lipoprotein-induced metabolic alterations and apoptosis in endothelial cells: a nondirected metabolomic studyAnabel García-Heredia, Judit Marsillach, Anna Rull, et al.
Atherosclerosis|September 1, 2006
Serum paraoxonase-1 activity and concentration are influenced by human immunodeficiency virus infectionSandra Parra, Carlos Alonso-Villaverde, Blai Coll, et al.
The Journal of Infectious Diseases|January 19, 2010
Paraoxonase-1 gene haplotypes are associated with metabolic disturbances, atherosclerosis, and immunologic outcome in HIV-infected patientsSandra Parra, Judit Marsillach, Gerard Aragonés, et al.
Lipids in Health and Disease|May 18, 2010
Decreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairmentJudit Marsillach, Gerard Aragonès, Bharti Mackness, et al.
Clinical Chemistry and Laboratory Medicine|August 8, 2012
Monocyte chemoattractant protein-1 and paraoxonase-1 and 3 levels in patients with sepsis treated in an intensive care unit: a preliminary reportTeresa Sans, Anna Rull, Jose Luna, et al.
Journal of Lipid Research|February 22, 2011
Measurement of serum PON-3 concentration: method evaluation, reference values, and influence of genotypes in a population-based studyGerard Aragonès, Marta Guardiola, María Barreda, et al.
Atherosclerosis|December 4, 2003
Phenotype-dependent and -independent actions of rosuvastatin on atherogenic lipoprotein subfractions in hyperlipidaemiaMuriel J Caslake, Grace Stewart, Stephen P Day, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Journal of Hepatology|March 3, 2006
Paraoxonase-1 is associated with oxidative stress, fibrosis and FAS expression in chronic liver diseasesNatàlia Ferré, Judit Marsillach, Jordi Camps, et al.
Journal of Molecular Histology|October 9, 2010
Tissue distribution and expression of paraoxonases and chemokines in mouse: the ubiquitous and joint localisation suggest a systemic and coordinated roleFernando Rodríguez-Sanabria, Anna Rull, Raúl Beltrán-Debón, et al.
Circulation|July 21, 2004
Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in womenMasoud El-Magadmi, Helena Bodill, Yasmeen Ahmad, et al.
Mediators of Inflammation|June 15, 2013
Paraoxonase-1 inhibits oxidized low-density lipoprotein-induced metabolic alterations and apoptosis in endothelial cells: a nondirected metabolomic studyAnabel García-Heredia, Judit Marsillach, Anna Rull, et al.
Atherosclerosis|September 1, 2006
Serum paraoxonase-1 activity and concentration are influenced by human immunodeficiency virus infectionSandra Parra, Carlos Alonso-Villaverde, Blai Coll, et al.
The Journal of Infectious Diseases|January 19, 2010
Paraoxonase-1 gene haplotypes are associated with metabolic disturbances, atherosclerosis, and immunologic outcome in HIV-infected patientsSandra Parra, Judit Marsillach, Gerard Aragonés, et al.
Lipids in Health and Disease|May 18, 2010
Decreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairmentJudit Marsillach, Gerard Aragonès, Bharti Mackness, et al.
Clinical Chemistry and Laboratory Medicine|August 8, 2012
Monocyte chemoattractant protein-1 and paraoxonase-1 and 3 levels in patients with sepsis treated in an intensive care unit: a preliminary reportTeresa Sans, Anna Rull, Jose Luna, et al.
Journal of Lipid Research|February 22, 2011
Measurement of serum PON-3 concentration: method evaluation, reference values, and influence of genotypes in a population-based studyGerard Aragonès, Marta Guardiola, María Barreda, et al.
Atherosclerosis|December 4, 2003
Phenotype-dependent and -independent actions of rosuvastatin on atherogenic lipoprotein subfractions in hyperlipidaemiaMuriel J Caslake, Grace Stewart, Stephen P Day, et al.
Pageof 3